Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ACE | P12821 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | GGH | Q92820 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 3/20 | 0.33 |
| ▸ | ECE1 | P42892 | 1/20 | 0.33 |
| ▸ | LAP3 | P28838 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42674 | 1.00 | TP53 (0.38) | TP53ACECA2CA1CA12 | |
| Glycine SCHEMBL10277141 | 0.89 | GLRA1 (0.36) | ACECA2CA1GGHMME | |
| Glycine SCHEMBL10277137 | 0.89 | GLRA1 (0.36) | ACECA2CA1GGHMME | |
| SCHEMBL6513519 | 0.86 | GGH (0.37) | ACECA2GGHMMEECE1 | |
| SCHEMBL7547247 | 0.80 | TP53 (0.36) | TP53CA2CA1MME | |
| Glutamine SCHEMBL6858577 | 0.79 | ALOX15 (0.54) | — | |
| Proline SCHEMBL442338 | 0.77 | ACE (0.40) | ACE | |
| SCHEMBL6297728 | 0.77 | ALDH1A1 (0.52) | ACECA2CA1MMP1MMP2 | |
| SCHEMBL30910287 | 0.77 | ALDH1A1 (0.52) | ACECA2CA1MMP1MMP2 | |
| SCHEMBL6297727 | 0.77 | ALDH1A1 (0.52) | ACECA2CA1MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 18035 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070942-A | Implant adhesive and preparation method and application thereof | 杭州源囊生物科技有限公司 | 2026-05-22 | — | — | CN | claimed |
| WO-2026102249-A1 | TNF RECEPTOR SUPERFAMILY AGONIST FUSION POLYPEPTIDES | ANKYRA THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| EP-4709434-A1 | CALCIUM PHOSPHATE POWDER COMPOSITION | Biomimetic Innovations Limited (IE) | 2026-03-18 | — | — | EP | claimed |
| US-20260062469-A1 | COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME | ABBRATECH INC (US) | 2026-03-05 | — | — | US | claimed |
| US-20260021177-A1 | IMMUNOMODULATORY FUSION PROTEIN-METAL HYDROXIDE COMPLEXES AND METHODS THEREOF | MASSACHUSETTS INST TECHNOLOGY (US) | 2026-01-22 | — | — | US | claimed |
| US-12509508-B2 | Compositions and methods for linear and conformational site-specific antibodies and methods of making the same | ABBRATECH, INC. (US) | 2025-12-30 | — | — | US | claimed |
| US-20250369983-A1 | COMPOSITIONS AND METHODS FOR OPTIMIZED IGG PRODUCTION | ABBRATECH INC (US) | 2025-12-04 | — | — | US | claimed |
| EP-4656203-A1 | COMPOSITIONS AND METHODS FOR OPTIMIZED IGG PRODUCTION | Abbratech Inc. (US) | 2025-12-03 | — | — | EP | claimed |
| EP-4634233-A2 | CHECKPOINT MODULATORS FOR ENHANCING IMMUNOTHERAPY | Dana-Farber Cancer Institute, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| US-4868287-A | ANTIDEPOSIT | UNIVERSITY OF SOUTH ALABAMA (US) | 1989-09-19 | — | — | US | claimed |
| US-4866161-A | Inhibition of tartar deposition by polyanionic/hydrophobic peptides and derivatives thereof which have a clustered block copolymer structure | UNIVERSITY OF SOUTH ALABAMA (US) | 1989-09-12 | — | — | US | claimed |
| EP-0305283-A2 | Inhibition of mineral deposition by polyanionic/hydrophobic peptides and derivatives thereof | UNIVERSITY OF SOUTH ALABAMA (US) | 1989-03-01 | — | — | EP | claimed |
| EP-0305282-A1 | Inhibition of tartar deposition by polyanionic/hydrophobic peptides and derivatives thereof | UNIVERSITY OF SOUTH ALABAMA (US) | 1989-03-01 | — | — | EP | claimed |
| EP-0268663-A1 | PHOSPHOPEPTIDES. | UNIV MELBOURNE (AU) | 1988-06-01 | — | — | EP | claimed |
| WO-1987007615-A1 | PHOSPHOPEPTIDES | THE UNIVERSITY OF MELBOURNE (AU) | 1987-12-17 | — | — | WO | claimed |
| EP-0166055-A2 | Caries inhibition | THE UNIVERSITY OF MELBOURNE (AU) | 1986-01-02 | — | — | EP | claimed |
| EP-0073210-A4 | CARIES INHIBITION. | UNIV MELBOURNE (AU) | 1985-06-10 | — | — | EP | claimed |
| EP-0073210-A1 | CARIES INHIBITION. | UNIV MELBOURNE (AU) | 1983-03-09 | — | — | EP | claimed |
| WO-1982003008-A1 | CARIES INHIBITION | REYNOLDS ERIC CHARLES | 1982-09-16 | — | — | WO | claimed |